|
Characteristics
| |
Total (n = 167)
|
URG4
|
Chi-square test P-value
|
Fisher’s exact test P-value
|
|---|
| |
Low expression
|
High expression
|
|---|
| |
(%)
|
(%)
| |
|---|
|
Age (y)
|
≥42
|
93
|
56 (60.2)
|
37 (39.8)
|
0.798
|
0.873
|
|
<42
|
74
|
46 (62.2)
|
28 (37.8)
|
|
Clinical stage
|
Ib1
|
68
|
57 (83.8)
|
11 (16.2)
|
0.000
|
0.000
|
|
Ib2
|
59
|
32 (54.2)
|
27 (45.8)
|
|
IIa1
|
38
|
19 (50.0)
|
19 (50.0)
|
|
IIa2
|
2
|
0 (0.0)
|
2 (100.0)
|
|
T classification
|
T1b1
|
113
|
74 (65.5)
|
39 (34.5)
|
0.005
|
0.003
|
|
T1b2
|
39
|
26 (66.7)
|
13 (33.3)
|
|
T2a
|
9
|
1 (11.1)
|
8 (88.9)
|
|
T2b
|
4
|
1 (25.0)
|
3 (75.0)
|
|
T4
|
2
|
0 (0.0)
|
2 (100.0)
|
|
N classification
|
N
0
|
140
|
91 (65.0)
|
49 (35.0)
|
0.001
|
0.002
|
|
N
1
|
27
|
11 (40.7)
|
16 (59.3)
|
|
M classification
|
Yes
|
7
|
4 (57.1)
|
3 (42.9)
|
0.827
|
1.000
|
|
No
|
160
|
98 (61.2)
|
62 (38.8)
|
|
Histological differentiation
|
Well
|
8
|
7 (87.5)
|
1 (12.5)
|
0.058
|
0.069
|
|
Moderate
|
66
|
34 (51.5)
|
32 (48.5)
|
|
Poor
|
93
|
61 (65.6)
|
32 (34.0)
|
|
Expression of SCC
|
≤1.5
|
97
|
64 (66.0)
|
33 (34.0)
|
0.289
|
0.291
|
|
>1.5
|
51
|
27 (52.9)
|
22 (47.1)
|
|
None
|
19
|
11 (57.9)
|
7 (42.1)
|
|
Tumour size, cm
|
<4
|
106
|
76 (71.7)
|
30 (28.3)
|
0.012
|
0.018
|
|
≥4
|
61
|
32 (52.5)
|
29 (47.5)
|
|
Histological type
|
Squamous cell carcinoma
|
153
|
92 (60.1)
|
61 (39.9)
|
0.407
|
0.569
|
|
Adeno cell carcinoma
|
14
|
10 (71.4)
|
4 (28.6)
|
|
Deep stromal invasion
|
Yes
|
100
|
55 (55.0)
|
45 (45.0)
|
0.123
|
0.139
|
|
No
|
67
|
47 (70.1)
|
20 (29.9)
|
|
Lymphovascular space involvement
|
Yes
|
7
|
3 (42.9)
|
4 (57.1)
|
0.312
|
0.433
|
|
No
|
160
|
99 (61.9)
|
61 (38.1)
|
|
Positive parametrium
|
Yes
|
5
|
2 (40.0)
|
3 (60.0)
|
0.326
|
0.378
|
|
No
|
162
|
100 (61.7)
|
62 (38.3)
|
|
Vaginal involvement
|
Yes
|
10
|
1 (10.0)
|
9 (90.0)
|
0.002
|
0.004
|
|
No
|
157
|
101 (64.3)
|
56 (35.7)
|
|
Positive surgical margin
|
Yes
|
3
|
1 (33.3)
|
2 (66.7)
|
0.320
|
0.561
|
|
No
|
164
|
101 (61.6)
|
63 (38.4)
|
